ArticleJournal of neuro-oncology2022

Quantifying intraventricular drug delivery utilizing programmable ventriculoperitoneal shunts as the intraventricular access device.

Sheila S McThenia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.